Volitionrx LTD (VNRX) SEC Filings — 2024
19 SEC filings for Volitionrx LTD (VNRX) in 2024.
Filings
- VolitionRx Limited Files 8-K with Material Agreement — 8-K · Dec 9, 2024
- Volitionrx LTD SC 13G Filing — SC 13G · Nov 14, 2024
- VolitionRx Ltd. Q3 2024 10-Q Filed — 10-Q · Nov 14, 2024
- Volitionrx LTD SC 13G Filing — SC 13G · Nov 14, 2024
- VolitionRx Appoints New CMO, Elects Director — 8-K · Nov 6, 2024
- VolitionRx Ltd Files 8-K on Officer/Director Changes — 8-K · Sep 30, 2024
- VolitionRx Ltd. Announces Board and Compensation Changes — 8-K · Sep 27, 2024
- VolitionRx to Acquire BioCheck for $10M — 8-K · Sep 16, 2024
- VolitionRx Ltd. Files Q2 2024 10-Q, Details Financials — 10-Q · Aug 14, 2024
- VolitionRx Limited Files 8-K — 8-K · Aug 12, 2024
- VolitionRx Ltd. Announces Board and Officer Changes — 8-K · Jul 3, 2024
- VolitionRx Limited Files 8-K Report — 8-K · Jun 27, 2024
- VolitionRx Ltd. Files 10-Q for Q1 2024 — 10-Q · May 13, 2024
- VolitionRx Appoints New CSO, Board Member — 8-K · Apr 26, 2024
- VolitionRx Ltd. Files 2023 Annual Report on Form 10-K — 10-K · Mar 25, 2024
- VolitionRx to Acquire Private Diagnostics Company — 8-K · Mar 19, 2024
- Volitionrx LTD SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- VolitionRx CEO Reynolds Amends 13D/A, Updates Ownership Stake — SC 13D/A · Feb 9, 2024
- VolitionRx 8-K: Administrative Update, NYSE American Listing Confirmed — 8-K · Jan 2, 2024